Pharmaceutical researchers speak of a hit when they come across a promising substance with a desired effect in early drug discovery. Unfortunately, hits are rarely bull’s-eyes, often showing undesirable side effects that not only complicate the search for new hits, but also the subsequent development into a drug. A new study could now help to better identify one of the most frequently observed side effects already in early drug discovery, but also to find new bioactivities.